Original Research

DOI: 10.4244/EIJ-D-25-00478

Optical coherence tomography-guided percutaneous coronary intervention in acute coronary syndrome patients with complex lesions: a subgroup analysis of the randomised OCCUPI Trial

Yong-Joon Lee1, MD; Yongcheol Kim2, MD; Oh-Hyun Lee2, MD; Deok-Kyu Cho2, MD; Sang-Hyup Lee1, MD; Seung-Jun Lee1, MD; Jong-Young Lee3, MD; Jin Won Kim4, MD; Sang Min Kim5, MD; Seung-Ho Hur6, MD; Jung Ho Heo7, MD; Ji-Yong Jang8, MD; Jin Sin Koh9, MD; Hoyoun Won10, MD; Jun-Won Lee11, MD; Soon Jun Hong12, MD; Dong-Kie Kim13, MD; Jeong Cheon Choe14, MD; Jin Bae Lee15, MD; Tae-Hyun Yang16, MD; Jung-Hee Lee11, MD; Young Joon Hong17, MD; Jong-Hwa Ahn18, MD; Sung-Jin Hong1, MD; Chul-Min Ahn1, MD; Jung-Sun Kim1, MD; Young-Guk Ko1, MD; Donghoon Choi1, MD; Myeong-Ki Hong1, MD; Yangsoo Jang1, MD; Byeong-Keuk Kim1, MD; on behalf of the OCCUPI investigators

Abstract

Background: The role of optical coherence tomography (OCT) guidance during percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS) remains inconclusive.

Aims: This study aimed to evaluate the impact of OCT-guided PCI in ACS patients with complex lesions.

Methods: The Optical CoherenCe Tomography-gUided Coronary Intervention in Patients With Complex Lesions (OCCUPI) Trial compared PCI with OCT guidance versus angiography guidance in patients who required drug-eluting stent implantation for complex lesions. This post hoc analysis focused on participants presenting with ACS. The primary outcome was 1-year major adverse cardiac events (a composite of cardiac death, myocardial infarction, stent thrombosis, or ischaemia-driven target vessel revascularisation).

Results: Out of 1,604 randomised patients, 790 (49.3%) and 814 (50.7%) presented with ACS and chronic coronary syndrome (CCS), respectively. Among patients with ACS, the incidence of the primary outcome was 4.9% in the OCT-guided group and 9.5% in the angiography-guided group (hazard ratio [HR] 0.50, 95% confidence interval [CI]: 0.29-0.87; p=0.011). Among patients with CCS, its incidence was 4.4% and 5.4%, respectively (HR 0.80, 95% CI: 0.43-1.50; p=0.479). No significant interaction between clinical presentation and imaging guidance strategy was observed for the primary outcome (pinteraction=0.273). Among patients with ACS randomised to OCT guidance, the achievement of stent optimisation by OCT was associated with a lower incidence of the primary outcome compared with suboptimisation (2.9% vs 9.7%; HR 0.29, 95% CI: 0.12-0.72; p=0.004).

Conclusions: In ACS patients with complex lesions, OCT-guided PCI demonstrated an evident cardiovascular benefit over angiography-guided PCI, a finding endorsed by current guidelines. (ClinicalTrials.gov: NCT03625908)

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 21
Nov 3, 2025
Volume 21 Number 21
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00048 Nov 3, 2025
A clear-sighted view is what is needed in a rough sea
Adriaenssens T and Frederiks P
free

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free

Debate

10.4244/EIJ-E-24-00008 May 10, 2024
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons
Ali ZA et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved